Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery

INTRODUCTION: Surgery in people with haemophilia and factor VIII inhibitors is typically managed with perioperative administration of haemostatic agents to prevent or control the occurrence of bleeding events. Practical experience of surgery in patients with inhibitors who are receiving treatment wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez‐Yuste, Victor, Rodríguez‐Merchán, E. Carlos, Matsushita, Tadashi, Holme, Pål Andrè
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359827/
https://www.ncbi.nlm.nih.gov/pubmed/33988293
http://dx.doi.org/10.1111/hae.14322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359827/
https://www.ncbi.nlm.nih.gov/pubmed/33988293
http://dx.doi.org/10.1111/hae.14322

Ejemplares similares